Cargando…

Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies

Objective To quantify the frequency and seriousness of adverse events in non-oncology phase I studies with healthy participants. Design Meta-analysis of individual, healthy volunteer level data. Setting Phase I studies with healthy volunteers conducted between September 2004 and March 2011 at Pfizer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emanuel, Ezekiel J, Bedarida, Gabriella, Macci, Kristy, Gabler, Nicole B, Rid, Annette, Wendler, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482145/ https://www.ncbi.nlm.nih.gov/pubmed/26115663 http://dx.doi.org/10.1136/bmj.h3271

Ejemplares similares

Morphological abnormalities in baseline ECGs in healthy normal volunteers participating in phase I studies
por: Hingorani, Pooja, et al.
Publicado: (2012)

Phase I clinical trials of anticancer drugs in healthy volunteers: Need for critical consideration
por: Gupta, Pooja, et al.
Publicado: (2012)

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
por: Radanovic, Igor, et al.
Publicado: (2022)

Topical administration of regorafenib eye drops: phase I dose‐escalation study in healthy volunteers
por: Zimmermann, Torsten, et al.
Publicado: (2018)

Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time
por: Kalbaugh, Corey A., et al.
Publicado: (2021)

Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese Volunteers
por: Wu, Guolan, et al.
Publicado: (2023)

Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research
por: Walker, Rebecca L, et al.
Publicado: (2018)

Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study
por: McDonald, Rebecca, et al.
Publicado: (2017)

Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study
por: Fisher, Jill A., et al.
Publicado: (2018)

Correction: Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time
Publicado: (2022)

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors
por: Zhu, Zhongling, et al.
Publicado: (2013)

Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers: Safety and Pharmacokinetics of Single or Multiple Intravenous Infusions
por: Li, Hao, et al.
Publicado: (2012)

The Lipid-lowering Effects of R-bambuterol in Healthy Chinese Volunteers: A Randomized Phase I Clinical Study
por: Ye, Yanrui, et al.
Publicado: (2015)

A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers
por: Wang, Jin, et al.
Publicado: (2019)

Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers
por: Boettcher, Michael, et al.
Publicado: (2020)

An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study
por: Kallend, David, et al.
Publicado: (2022)

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
por: Printz, Marie A., et al.
Publicado: (2020)

A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers
por: Addo, S, et al.
Publicado: (2002)

A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers
por: Knight, Beverly, et al.
Publicado: (2016)

Effect of Thunbergia laurifolia Herbal Tea on Glucose Homeostasis in Healthy Volunteers: A Single-Arm Phase I Study
por: Preechasuk, Lukana, et al.
Publicado: (2020)

Picking and Choosing Among Phase I Trials: A Qualitative Examination of How Healthy Volunteers Understand Study Risks
por: Fisher, Jill A., et al.
Publicado: (2019)

Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers
por: Zou, Chan, et al.
Publicado: (2019)

Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
por: Fisher, Jill A, et al.
Publicado: (2021)

Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers
por: Zhu, Rui, et al.
Publicado: (2022)

Excretion of mephedrone and its phase I metabolites in urine after a controlled intranasal administration to healthy human volunteers
por: Czerwinska, Joanna, et al.
Publicado: (2022)

Phase I oncology trials incorporating patient choice of dose
por: Huson, L W
Publicado: (2012)

Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers
por: Pinato, David J., et al.
Publicado: (2012)

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
por: Cossu, Maria Vittoria, et al.
Publicado: (2014)

Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers
por: Cullberg, Marie, et al.
Publicado: (2018)

A phase I single-blind clinical trial to evaluate the safety of oil palm phenolics (OPP) supplementation in healthy volunteers
por: Fairus, Syed, et al.
Publicado: (2018)

A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India
por: Sharma, Hitt, et al.
Publicado: (2023)

Informed Consent for Phase I Oncology Trials: Form, Substance and Signature
por: Malik, Laeeq, et al.
Publicado: (2014)

Communication about the Risks and Benefits of Phase I Pediatric Oncology Trials
por: Hazen, Rebecca A., et al.
Publicado: (2015)

Drug induced interstitial lung disease in oncology phase I trials
por: Yonemori, Kan, et al.
Publicado: (2016)

Phase I dose-escalation oncology trials with sequential multiple schedules
por: Günhan, Burak Kürsad, et al.
Publicado: (2021)

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers
por: Chilengi, Roma, et al.
Publicado: (2011)

Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single-center, phase I, randomized, four-way crossover study
por: Breitschaft, Astrid, et al.
Publicado: (2014)

A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers
por: Shin, Donghoon, et al.
Publicado: (2020)

Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial
por: ESKANDARI, Seyed Ebrahim, et al.
Publicado: (2019)

Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I–III Clinical Trials
por: Suleiman, Ahmed A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vh2hquni82sbjv8q856ft7hsdr